Riskpilot← Back to searchSign inGet full accessObliquus fysioterapi AB
ABActiveOrg 5568845324Gåsenvägen 29Physiotherapy activities · NACE 8695Est. 20121 employees
Revenue 2025
SEK 861K
+14% vs 2024
EBITDA margin
28.9%
+425% vs 2024
Equity ratio
40.7%
Financial strength
Net profit 2025
SEK 173K
+221% vs 2024
| Revenue | SEK 861K | +14% |
| EBITDA | SEK 249K | +425% |
| Net profit | SEK 173K | +221% |
| Total assets | SEK 575K | +54% |
| Equity | SEK 234K | +282% |
| Employees | 1 | — |
Legal name
Obliquus fysioterapi AB
Org number
5568845324
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
16 februari 2012
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva sjukgymnastik, rehabiliteringsutredningar, konsultationer, föreläsningar och utbildning inom samma branscher, behandling av belastnings- och idrottsskador samt annan därmed förenlig verksamhet.
Address
Gåsenvägen 29
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 998 | 956 | 947 | 754 | 861 |
| Staff expenses | — | −664 | −646 | −653 | −410 |
| EBITDA | −12 | 78 | 76 | −77 | 249 |
| Depreciation & amort. | −36 | −62 | −62 | −62 | −62 |
| EBIT | −48 | 16 | 14 | −139 | 187 |
| Net financials | — | −0 | 13 | −4 | −14 |
| Profit before tax | −48 | 16 | 27 | −143 | 173 |
| Tax | −0 | — | — | — | — |
| Net profit | −48 | 16 | 27 | −143 | 173 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 610 | 562 | 626 | 373 | 575 |
| Equity | 162 | 177 | 205 | 61 | 234 |
| Long-term debt | 311 | 261 | 398 | 298 | 314 |
| Short-term debt | 137 | 124 | 23 | 13 | 27 |
| Total debt | 448 | 385 | 421 | 311 | 341 |
EBITDA margin
28.9%
This company
15.8%
Market median
+83% vs market
20212025
Equity ratio
40.7%
This company
38.2%
Market median
+7% vs market
20212025
Return on equity
73.8%
This company
18.4%
Market median
+301% vs market
20212025
Net profit margin
20.1%
This company
8.1%
Market median
+148% vs market
20212025
Asset turnover
1.50×
This company
1.12×
Market median
+34% vs market
20212025
Debt / equity
1.46×
This company
0.62×
Market median
-135% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Obliquus fysioterapi AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lena Hägglund | Board of Directors | 0 companies |
| Erik Anders Hägglund | Deputy Board Member | 0 companies |